These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 38300642)

  • 1. Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia.
    Liu R; Collier JM; Abdul-Rahman NH; Capuk O; Zhang Z; Begum G
    Aging Dis; 2024 Aug; 15(4):1748-1770. PubMed ID: 38300642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rare Marine Bioactive Compounds in Neurological Disorders and Diseases: Is the Blood-Brain Barrier an Obstacle or a Target?
    Diao X; Han H; Li B; Guo Z; Fu J; Wu W
    Mar Drugs; 2023 Jul; 21(7):. PubMed ID: 37504937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies.
    Alkhalifa AE; Al-Ghraiybah NF; Odum J; Shunnarah JG; Austin N; Kaddoumi A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of capillary pericytes and the blood-brain barrier in white matter in poststroke and vascular dementias and Alzheimer's disease.
    Ding R; Hase Y; Ameen-Ali KE; Ndung'u M; Stevenson W; Barsby J; Gourlay R; Akinyemi T; Akinyemi R; Uemura MT; Polvikoski T; Mukaetova-Ladinska E; Ihara M; Kalaria RN
    Brain Pathol; 2020 Nov; 30(6):1087-1101. PubMed ID: 32705757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
    Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
    Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Dysfunction in Neurodegenerative Diseases.
    Fang YC; Hsieh YC; Hu CJ; Tu YK
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells.
    Lauschke K; Frederiksen L; Hall VJ
    Stem Cells Dev; 2017 Jun; 26(12):857-874. PubMed ID: 28398169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment.
    Chaves JCS; Dando SJ; White AR; Oikari LE
    Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166967. PubMed ID: 38008230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.
    Erickson MA; Banks WA
    J Cereb Blood Flow Metab; 2013 Oct; 33(10):1500-13. PubMed ID: 23921899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier alterations in ageing and dementia.
    Popescu BO; Toescu EC; Popescu LM; Bajenaru O; Muresanu DF; Schultzberg M; Bogdanovic N
    J Neurol Sci; 2009 Aug; 283(1-2):99-106. PubMed ID: 19264328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Modeling of the Blood-Brain Barrier for the Study of Physiological Conditions and Alzheimer's Disease.
    Schreiner TG; Creangă-Murariu I; Tamba BI; Lucanu N; Popescu BO
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.
    Desai BS; Monahan AJ; Carvey PM; Hendey B
    Cell Transplant; 2007; 16(3):285-99. PubMed ID: 17503739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment.
    Van Skike CE; Jahrling JB; Olson AB; Sayre NL; Hussong SA; Ungvari Z; Lechleiter JD; Galvan V
    Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H693-H703. PubMed ID: 29351469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
    Bell RD; Zlokovic BV
    Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-Brain Barrier: From Physiology to Disease and Back.
    Sweeney MD; Zhao Z; Montagne A; Nelson AR; Zlokovic BV
    Physiol Rev; 2019 Jan; 99(1):21-78. PubMed ID: 30280653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity-induced blood-brain barrier dysfunction: phenotypes and mechanisms.
    Feng Z; Fang C; Ma Y; Chang J
    J Neuroinflammation; 2024 Apr; 21(1):110. PubMed ID: 38678254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease.
    Sekhar GN; Fleckney AL; Boyanova ST; Rupawala H; Lo R; Wang H; Farag DB; Rahman KM; Broadstock M; Reeves S; Thomas SA
    Fluids Barriers CNS; 2019 Dec; 16(1):38. PubMed ID: 31842924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.
    Abdullahi W; Tripathi D; Ronaldson PT
    Am J Physiol Cell Physiol; 2018 Sep; 315(3):C343-C356. PubMed ID: 29949404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier Na transporters in ischemic stroke.
    O'Donnell ME
    Adv Pharmacol; 2014; 71():113-46. PubMed ID: 25307215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.